SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-025892
Filing Date
2023-07-28
Accepted
2023-07-28 16:30:28
Documents
3
Period of Report
2023-07-28

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 410650
2 proxy_001.jpg GRAPHIC 275117
3 proxy_002.jpg GRAPHIC 345651
  Complete submission text file 0001493152-23-025892.txt   1267021
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-35570 | Film No.: 231123530
SIC: 2834 Pharmaceutical Preparations